Lumos Pharma, Inc.
LUMO · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7 | -$8 | -$10 | -$9 |
| Dep. & Amort. | -$0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1 | $1 |
| Change in WC | $2 | $1 | -$3 | $2 |
| Other Non-Cash | -$0 | -$0 | $3 | -$0 |
| Operating Cash Flow | -$5 | -$6 | -$13 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$13 |
| Net Acquisitions | $0 | $0 | $0 | $7 |
| Inv. Purchases | $0 | $0 | $0 | -$1 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $7 |
| Other Inv. Act. | -$1 | $0 | $1 | $6 |
| Investing Cash Flow | $0 | $0 | $1 | $6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1 |
| Stock Repurch. | $0 | -$0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | $0 |
| Financing Cash Flow | $2 | $0 | -$0 | $1 |
| Forex Effect | $0 | $0 | $0 | $9 |
| Net Chg. in Cash | -$3 | -$6 | -$12 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17 | $23 | $35 | $36 |
| End Cash | $14 | $17 | $23 | $35 |
| Free Cash Flow | -$5 | -$6 | -$13 | -$21 |